[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100602077":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":14,"responsibleParty":31,"collaborators":7,"id":33,"slug":7,"hasResults":34,"nctId":35,"briefTitle":36,"officialTitle":37,"acronym":7,"eligibilityCriteria":38,"healthyVolunteers":34,"sex":39,"minAge":40,"maxAge":7,"enrollmentInfo":41,"targetDuration":7,"studyType":44,"phases":7,"briefSummary":45,"conditions":46,"keywords":7,"overallStatus":17,"whyStopped":7,"lastUpdateSubmitDate":48,"lastUpdatePostDateStruct":49,"startDateStruct":52,"completionDateStruct":54,"leadSponsor":56,"locationsCount":57},{"fullName":5,"class":6},"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","OTHER",null,[9],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Lian Yang","CONTACT","18986273791","yanglian@hust.edu.cn",[15],{"facility":16,"status":17,"city":18,"state":19,"zip":20,"country":21,"countryCode":22,"cosmosGeoPoint":23,"geoPoint":28,"contacts":29},"Union Hospital，Tongji Medical College，Huazhong University of Science and Technology","RECRUITING","Wuhan","Hubei","430000","China","CN",{"type":24,"coordinates":25},"Point",[26,27],114.26667,30.58333,{"lat":27,"lon":26},[30],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},{"type":32,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100602077",false,"NCT07118813","Application of Radiomics-based AI Models in Predicting Clinical Outcome of Patients With Renal Cell Carcinoma After Surgical Treatment","Application of Radiomics-based AI Models in Predicting Clinical Outcome of Patients With Renal Cell Carcinoma After Surgical Treatment (AI-Kidney-Prognosis)","Inclusion Criteria:\n\n1. Patients were treated for renal cell carcinoma in Wuhan Union Hospital from August 2025 to August 2026;\n2. Aged \\> 18 years old;\n3. At least one abdominal CT scan before treatment;\n4. Tissue biopsy pathological examination confirmed the diagnosis of renal cell carcinoma.\n\nExclusion Criteria:\n\n1. Poor image quality;\n2. Incomplete clinical data or loss of follow-up;\n3. Presence of another primary malignancy other than renal cell carcinoma;\n4. Unclear pathological diagnosis.","ALL","18 Years",{"count":42,"type":43},400,"ESTIMATED","OBSERVATIONAL","This is a prospective observational cohort study (AI-Kidney-Prognosis), aiming to non-invasively predict the clinical outcomes in renal cell carcinoma patients after surgical treatment using radiomics-based AI models, thereby assisting clinical decision-making and personalized follow-up strategies.",[47],"Renal Cell Carcinoma (Kidney Cancer)","2025-08-05",{"date":50,"type":51},"2025-08-12","ACTUAL",{"date":53,"type":43},"2025-08",{"date":55,"type":43},"2026-08",{"name":5,"class":6},1]